High-dose vitamin D linked to better cognition in at-risk adults

What Happened

Researchers at Emory University examined whether vitamin D supplementation is linked to cognitive performance in adults who have sleep disturbances and mild cognitive impairment (MCI), conditions that can precede dementia. In a study published in Sleep Medicine, they reported that daily intake of 5,000 IU or more of vitamin D was associated with better cognitive performance, as measured by the Montreal Cognitive Assessment (MoCA). The association remained after adjusting for age, sex, body mass index, and education. Participants consisted of 54 adults diagnosed with or suspected of having sleep disturbance and MCI. The study also found no significant cognitive differences between vitamin D2 and vitamin D3 forms. The senior author is Victoria Pak, an associate professor at Emory University’s Nell Hodgson Woodruff School of Nursing.

Why It Matters

The findings point to a potential, accessible intervention—high-dose vitamin D supplementation—for people showing early cognitive decline signs and sleep problems, a combination often linked to dementia risk. The researchers emphasize that this may be a critical window for brain-health interventions during the early stages of cognitive changes, although they note the study is preliminary.

Background

The headline context notes that more than 7 million people in the United States live with Alzheimer’s disease and dementia, with forecasts suggesting the number could nearly double by 2050. The study’s premise connects sleep disturbance and MCI as possible early indicators of dementia risk, and investigates whether vitamin D intake could influence cognitive performance in this at-risk group. The research team used self-reported data for vitamin D supplement intake and evaluated cognition using MoCA. The study is described as the first to assess the link between vitamin D supplementation and global cognition in individuals with both sleep disturbance and MCI.

Key Facts

• Location of the study: Emory University, Georgia, United States
• Population: 54 adults with sleep disturbance and mild cognitive impairment (or suspected MCI)
• Daily vitamin D dose associated with better cognition: 5,000 IU or more
• Assessment tool for cognition: Montreal Cognitive Assessment (MoCA)
• Vitamin D forms examined: vitamin D2 and vitamin D3 (no difference in cognitive outcomes between them)
• Statistical adjustment factors: age, sex, body mass index, education
• Senior author: Victoria Pak, associate professor at Emory University’s Nell Hodgson Woodruff School of Nursing
• Publication venue: Sleep Medicine
• Broader context: high prevalence of Alzheimer’s and dementia; sleep disturbances common among those at risk

What Happens Next

The source material notes the study is preliminary and emphasizes the timing of potential interventions in the early stages of cognitive decline. It does not specify planned follow-up trials or official next steps, only that identifying modifiable factors like vitamin D intake could become increasingly important as dementia risk rises.